DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mozenavir
Mozenavir
(12) Patent Application Publication (10) Pub. No.: US 2008/0306098 A1 Mutz Et Al
Download Article PDF/Slides
( 12 ) United States Patent
Modifications to the Harmonized Tariff Schedule of the United States To
This Project Has Been Supported with Unrestriced Grants from Abbvie Gilead Sciences HEXAL Janssen-Cilag MSD Viiv Healthcare By
HIV Medicine 2003
Downloaded In.Sdf Format from the Pubchem Database (
Current and Novel Inhibitors of HIV Protease
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Antiviral Drugs in the Treatment of Aids: What Is in the Pipeline ?
Shudda, Cudda, Wudda. Reevaluating the Treatment
Hoffmann Rockstroh |
(12) United States Patent (10) Patent No.: US 6,531,484 B2 Willoughby Et Al
Repurposing of FDA Approved Drugs
New HIV Protease Inhibitors for Drug-Resistant Viruses
(Hiv) Protease Inhibitors Using Cellulosic Surface
Periodic Classification of Human Immunodeficiency Virus Inhibitors
Top View
WO 2013/116720 Al 8 August 2013 (08.08.2013) P O P C T
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
HIV Protease Inhibition: Limited Recent Progress and Advances in Understanding Current Pitfalls
HICDEP: HIV Cohorts Data Exchange Protocol
New Developments in Anti-HIV Chemotherapy $
(12) United States Patent (10) Patent No.: US 9,090,653 B2 Aciro Et Al
Hiv 2020/2021
(12) United States Patent (10) Patent No.: US 9,708,342 B2 Carra Et Al
HIV Protease Inhibitors: a Review of Molecular Selectivity and Toxicity
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors
WO 2015/196116 Al 23 December 2015 (23.12.2015) P O P C T
(12) Patent Application Publication (10) Pub. No.: US 2010/0166806 A1 Castor (43) Pub
Drug Resistance Mechanisms and Drug Design Strategies for Human Immunodeficiency Virus and Hepatitis C Virus Proteases Yong Wang Wayne State University
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WO 2012/151165 Al 8 November 2012 (08.11.2012) P O P C T
With an Unrestricted Grant from Boehringer-Ingelheim by Marcus Altfeld, Boston (USA) Georg Behrens, Hannover Patrick Braun, Aachen U
Computational Studies of HIV-1 Protease Inhibitors
Rational Approach to Aids Drug Design Through Structural Biology